Population pharmacokinetics of continuous infusion ceftazidime (vol 37, pg 343, 1999)

被引:0
|
作者
Frame, BC
Facca, BF
Nicolau, DP
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
下载
收藏
页码:40 / 40
页数:1
相关论文
共 50 条
  • [31] PHARMACOKINETICS OF CEFTAZIDIME IN ADULT CYSTIC-FIBROSIS PATIENTS DURING CONTINUOUS-INFUSION AND AMBULATORY TREATMENT AT HOME
    VINKS, AATMM
    TOUW, DJ
    HEIJERMAN, HGM
    DANHOF, M
    DELEEDE, GPJ
    BAKKER, W
    THERAPEUTIC DRUG MONITORING, 1994, 16 (04) : 341 - 348
  • [32] Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter (vol 37, pg 343, 2014)
    Freifeld, Clark C.
    Brownstein, John S.
    Menone, Christopher M.
    Bao, Wenjie
    Filice, Ross
    Kass-Hout, Taha
    Dasgupta, Nabarun
    DRUG SAFETY, 2014, 37 (07) : 555 - 555
  • [33] The catastrophic misinterpretation of physiological distress. (vol 37, pg 1105, 1999)
    Moore, MC
    Zebb, BJ
    BEHAVIOUR RESEARCH AND THERAPY, 2000, 38 (09) : 965 - 966
  • [34] Skin carriage of acinetobacters in Hong Kong (vol 37, pg 2962, 1999)
    Chu, YW
    Leung, CM
    Houang, ETS
    Ng, KC
    Leung, CB
    Leung, HY
    Cheng, AFB
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) : 4206 - 4206
  • [35] Threatened and uncommon plants of New Zealand (vol 37, pg 603, 1999)
    de Lange, PJ
    Heenan, PB
    Given, DR
    Norton, DA
    Ogle, CC
    Johnson, PN
    Cameron, EK
    NEW ZEALAND JOURNAL OF BOTANY, 2000, 38 (01) : 151 - 151
  • [36] Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis (vol 49, pg 445, 2000)
    Angus, BJ
    Smith, MD
    Suputtamongkol, Y
    Mattic, H
    Walsh, AL
    Wuthiekanun, V
    Chaowagul, W
    White, NJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (02) : 183 - 191
  • [37] Optimal forest rotation with in situ preferences (vol 37, pg 106, 1999)
    Tahvonen, O
    Salo, S
    JOURNAL OF ENVIRONMENTAL ECONOMICS AND MANAGEMENT, 1999, 38 (02) : 247 - 247
  • [38] Population pharmacokinetics analysis of patients receiving enoxaparin by continuous intravenous infusion.
    Feng, Y
    Bies, RR
    Bobek, MB
    Kane, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P30 - P30
  • [39] Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients
    Leegwater, E.
    Kraaijenbrink, B. V. C.
    Moes, D. J. A. R.
    Purmer, I. M.
    Wilms, E. B.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1554 - 1558
  • [40] Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients
    Facca, B
    Frame, B
    Triesenberg, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1783 - 1787